NCT05370456

Brief Summary

The primary aim of this study is to evaluate whether the effect of HA in combination with XCM for the treatment of MAGRs with a multiple coronally advanced flap technique (mCAF) achieves better results than the XCM with mCAF alone in terms of recession reduction (primary outcome) and other secondary root coverage outcomes (e.g. complete root coverage, mean root coverage). Moreover, this study aims to compare secondary clinical variables (e.g. keratinized tissue width (KTW) changes, probing pocket depth (PPD) changes, volumetric gain (VG), etc.), also with a digital approach, the patient-reported outcome measures (PROMs e.g. pain, swelling, bleeding) and lastly the expression of molecular mediators of tissue healing/regeneration. The hypothesis of this study is that at 6 months and 1 year follow-up the mCAF with XCM+HA is superior to the mCAF with only XCM in terms of recessions reduction and secondary clinical variables, including PROMs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2022

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 6, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 11, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2024

Completed
Last Updated

May 19, 2022

Status Verified

May 1, 2022

Enrollment Period

2.4 years

First QC Date

May 6, 2022

Last Update Submit

May 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean Recession Reduction (RecRed)

    Mean changes in mm in recession depth between baseline and 1-year

    6 months; 1 year

Secondary Outcomes (4)

  • Complete Root Coverage (CRC)

    6 months; 1 year

  • Mean Root Coverage (MRC)

    6 months; 1 year

  • Keratinised tissue height (KTH) changes

    6 months; 1 year

  • Post-operative morbidity (pain, swelling, discomfort)

    14 days

Study Arms (2)

Xenogenic collagen matrix (XCM) + Hyaluronic acid (HA)

EXPERIMENTAL

Multiple coronally advanced flap technique (mCAF) with the use of a XCM in combination with local application of a HA gel

Device: Local application of a HA gel for the treatment of MAGRs with mCAF technique and XCM

Xenogenic collagen matrix (XCM)

ACTIVE COMPARATOR

Multiple coronally advanced flap technique (mCAF) with the use of a XCM

Procedure: Treatment of MAGRs with mCAF technique and XCM

Interventions

After local anaesthesia, mCAF technique with two releasing vertical incisions will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction and HA gel will be applied.

Xenogenic collagen matrix (XCM) + Hyaluronic acid (HA)

After local anaesthesia, mCAF technique with two releasing vertical incisions will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction.

Xenogenic collagen matrix (XCM)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old and able to sign informed consent
  • At least 2 adjacent teeth with RT1 and/or RT2 gingival recessions without interproximal exposure of the CEJ (interdental gingival recession), at least one with a depth of ≥2mm with indication for root coverage treatment
  • A minimum of 4 adjacent teeth (including the ones to be treated) in the region of interest
  • Available to attend study related procedures (including follow-up visits)

You may not qualify if:

  • Systemic diseases/medications which could influence the outcome of the therapy (e.g., uncontrolled diabetes mellitus);
  • Current smokers (self-reported, any type of smoking), users of chewing tobacco, and drug/alcohol abusers;
  • Pregnant or nursing women;
  • History of previous periodontal surgery (mucogingival or other) on the teeth to be included;
  • Furcation involvement in the teeth to be included;
  • Presence of severe tooth malposition, rotation or clinically significant extrusion in the teeth to be treated;
  • Presence of fixed or removable prosthesis in the area to be treated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Turin

Turin, 10126, Italy

RECRUITING

MeSH Terms

Conditions

Gingival Recession

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Central Study Contacts

Mario Aimetti, PA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2022

First Posted

May 11, 2022

Study Start

May 3, 2022

Primary Completion

September 10, 2024

Study Completion

September 10, 2024

Last Updated

May 19, 2022

Record last verified: 2022-05

Locations